Invention Grant
- Patent Title: Chromenopyridine derivatives as phosphatidylinositol phosphate kinase inhibitors
-
Application No.: US16956981Application Date: 2018-12-21
-
Publication No.: US11584763B2Publication Date: 2023-02-21
- Inventor: Johan Lindström , Lars Boukharta Persson , Jenny Viklund , Rickard Forsblom , Tobias Ginman , Edward A. Kesicki , Eugene R. Hickey , Markus K. Dahlgren , Aleksey I. Gerasyuto
- Applicant: HIBERCELL, INC.
- Applicant Address: US NY New York
- Assignee: HIBERCELL, INC.
- Current Assignee: HIBERCELL, INC.
- Current Assignee Address: US NY New York
- Agency: Goodwin Procter LLP
- International Application: PCT/US2018/067261 WO 20181221
- International Announcement: WO2019/126730 WO 20190627
- Main IPC: C07D519/00
- IPC: C07D519/00 ; C07D491/052 ; C07D401/04 ; A61K9/00
Abstract:
The invention relates to inhibitors of PI5P4K inhibitors useful in the treatment of cancers, neurodegenerative diseases, inflammatory disorders, and metabolic diseases, having the Formula: where A1, A2, G, R1, R2, R3, R4, and W are described herein.
Public/Granted literature
- US11535635B2 Chromenopyridine derivatives as phosphatidylinositol phosphate kinase inhibitors Public/Granted day:2022-12-27
Information query
